KORRO BIO, INC.
Last · NasdaqCM$9.37-0.79 (-7.78%)stale · yahoo · 58h ago
Vol 140.3K ≈ 1.31M
MA10MA20MA50
Market cap$137.98M14.7M sh
P/E · TTM-1.1fwd -2.1 · eps -9.88 · loss
Beta2.36vs S&P 500
Div yield0.00%annual · TTM
52w range
$5.204$55.89
Volume140.3Ksession
Issuer
Legal nameKORRO BIO, INC.
HQUnited States (US)
ListingUS KRRO
ISINUS5009461089
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001703647
CIK0001703647
Websitewww.korrobio.com
Employees49
Loading chart…
Upcoming earnings
THU.12NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.26
Est. revenue
187,500
Press & signals
- GlobeNewswire
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)